| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Pharmacy Insurance Corporation of America - PICA is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CCS Cell Culture Service is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Natura Life+Science, we are focused on creating the world`s most sophisticated platform for the production and distribution of cannabis products. We will commercialize the industry in the most responsible manner, and positively affect millions of lives.Established in Sacramento, California in 2018.
Family Home Health Services is a Monroeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.